Evidence map›Paper›PMID 38356958›Full record

ArticleFrontiers in endocrinology2024

Poor serum uric acid control increases risk for developing hypertension: a retrospective cohort study in China.

Zeyin Lin, Shaoyan Wu, Zhe Chen, Weijian Luo, Zhihui Lin, Honghui Su, Dongming Guo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zeyin LinDepartment of Ultrasound, the First Affiliated Hospital of Shantou University Medical College, Shantou, China.
Shaoyan WuDepartment of Interventional Ultrasound, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Zhe ChenDepartment of Interventional Ultrasound, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Weijian LuoDepartment of Interventional Ultrasound, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Zhihui LinDepartment of Interventional Ultrasound, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Honghui SuDepartment of Interventional Ultrasound, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Dongming GuoDepartment of Interventional Ultrasound, the Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Shantou University · CNSecond Affiliated Hospital of Shantou University Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Serum uric acid (SUA) has been suggested as a contributor of hypertension. However, reports on the relationship between changes in SUA and hypertension are limited. Hence, we aimed to investigate the potential impact of SUA, especially its change over time, on hypertension incidence. Methods: This dynamic cohort included 6052 participants without hypertension at baseline. Participants were categorized into six grades based on whether baseline SUA was high and whether changes in SUA progressed to hyperuricemia or decreased to normal levels. Grades 1 to 6 represented the participants' SUA control from best to worst. Logistic regression and restricted cubic spline (RCS) models were used to explore the association of the grades of SUA control and hypertension incidence. Results: During a median follow-up of 6 years, 2550 (42.1%) participants developed hypertension. After adjusting confounding factors, compared to grade 1 with the best control of SUA, the odds ratios for grades 2 to 6 with worse control were 1.347 (1.109-1.636), 1.138 (0.764-1.693), 1.552 (1.245-1.934), 1.765 (1.170-2.663), and 2.165 (1.566-2.993), respectively. RCS indicated a linear correlation between the risk of hypertension and changes in SUA, and an elevated risk in participants with baseline hyperuricemia. Subgroup analyses showed that grades of SUA control had an interaction with systolic ( Conclusion: Poor SUA control, an increase in SUA over time, rises the risk of developing hypertension regardless of whether the initial SUA is normal or not. Initial hyperuricemia will exacerbate this risk. Effective SUA control should be an important measure for primary prevention of hypertension.

Indexed as

HypertensionHyperuricemiaChinaHumansRetrospective StudiesRisk FactorsUric AcidUric Acidblood pressureepidemiologyhypertensionrisk factorsuric acid

Identifiers

PMID38356958
PMCPMC10864606
OpenAlexW4391397547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.